You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Heparin Sodium 10,000 Units In Sodium Chloride 0.9%, and when can generic versions of Heparin Sodium 10,000 Units In Sodium Chloride 0.9% launch?

Heparin Sodium 10,000 Units In Sodium Chloride 0.9% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin Sodium 10,000 Units In Sodium Chloride 0.9%

A generic version of HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% was approved as heparin sodium by HOSPIRA on April 28th, 1983.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%?
  • What are the global sales for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%?
  • What is Average Wholesale Price for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%?
Summary for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%
Drug patent expirations by year for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%
Recent Clinical Trials for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vaneltix Pharma, Inc.Phase 2
Prevail Infoworks, IncPhase 2
The First Affiliated Hospital with Nanjing Medical UniversityN/A

See all HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% clinical trials

Pharmacology for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%

US Patents and Regulatory Information for HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% heparin sodium INJECTABLE;INJECTION 018911-003 Jan 30, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% heparin sodium INJECTABLE;INJECTION 018916-002 Jan 31, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.